OrganOx is delighted to announce that it has achieved CE certification for the OrganOx metra.
OrganOx CEO, Dr Les Russell commented: "The metra is the world's first portable liver perfusion device to achieve regulatory approval. Securing the CE mark is a fabulous team effort from OrganOx and a significant achievement for the company.
We continue to make excellent progress in our randomised clinical studies, including our large scale COPE trial supported with funding from the European Union. It is our expectation that the use of this new technology will help in improving patients' lives and alleviating the severe shortage of organs for transplantation".
For further information contact us